Home » Topics » Regulatory » Patents

Patents
RSS

Novartis discloses mTORC1 inhibitors

Oct. 8, 2020

Gilead Sciences patents new HIV antivirals

Oct. 8, 2020

Fulcrum Therapeutics discovers new EED inhibitors

Oct. 7, 2020

University of California identifies new EGFR inhibitors

Oct. 7, 2020

University of Maryland synthesizes new Mcl-1 and Bcl-2 dual inhibitors

Oct. 7, 2020

Cortexyme discloses Porphyromonas gingivalis RgpB inhibitors

Oct. 7, 2020

Chiba Prefecture patents new compounds targeting mitochondrial DNA mutations

Oct. 7, 2020

NuvoBio patents N-lysine methyltransferase KMT5A inhibitors

Oct. 6, 2020

Central China Normal University synthesizes new TRK inhibitors

Oct. 6, 2020

Kyushu University presents new lysosomal alpha-glucosidase inhibitors

Oct. 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...